Collaboration Details

Print  Close

Title of Collaborative Activity:

Endocrinologic and Metabolic Drugs Advisory Committee

Description of Collaborative Activity:

This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval.

Type of Collaborative Activity:

Advisory Group

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: